What are the contraindications, warnings, and precautions for insulin?
- Hypoglycemia (low blood sugar)
- Hypersensitivity to insulin or its excipients (inactive co-ingredients)
Warnings and Precautions
- Hypoglycemia may occur and is the most common side effect of insulin treatment.
- Severe, life-threatening allergic reactions, including anaphylaxis, may occur.
- Hypokalemia (low blood potassium) may occur because insulin stimulates movement of potassium from blood into cells. Combining insulin with potassium-lowering drugs may increase the risk of hypokalemia.
- Hepatic (liver) impairment may reduce the insulin requirement.
- Renal (kidney) dysfunction may reduce the insulin requirement.
- Illness, emotional disturbance, or other stress may alter the insulin requirement.
- Intravenous administration increases the risk of hypoglycemia and hypokalemia.
Which drugs interact with insulin?
Insulin Drug Interactions
|Drug or Drug Class||Effect||Recommendation|
|Beta blockers (for example, propranolol [Inderal, Inderal LA, Innopran XL], atenolol [Tenormin])||Beta blockers may mask symptoms of hypoglycemia or prolong hypoglycemia and alter glucose metabolism||Avoid combination if possible|
|repaglinide (Prandin)||Increased risk of hypoglycemia and heart attack (myocardial infarction)||Avoid combination if possible|
|rosiglitazone (Avandia) or rosiglitazone combination products||Increased incidence of hypoglycemia, fluid retention, ischemia (manifest by angina or heart pain), congestive heart failure||Avoid combination if possible|
|Thiazides and thiazide combination products||Hyperglycemia; may reduce effect of insulin||Monitor glucose levels and adjust accordingly|
|Corticosteroids||Hyperglycemia; may reduce effect of insulin||Monitor glucose levels and adjust accordingly|
|Estrogens||Hyperglycemia; may reduce effect of insulin||Monitor therapy and adjust as needed|
|levofloxacin (Levaquin) and other fluoroquinolones||Increased risk of hypoglycemia or hyperglycemia||Use with caution, monitor therapy|
|Monoamine oxidase inhibitors (MAOIs)||MAIOs may increase insulin secretion. Combination increases risk of prolonged hypoglycemia.||Monitor glucose levels and adjust accordingly|
|Sulfonylureas||Increased risk of hypoglycemia and||Monitor glucose levels and adjust accordingly|
|Thyroid hormones||Thyroid hormones may increase insulin requirement||Monitor glucose levels and adjust accordingly|
|Yohimbe||Yohimbe may increase risk of hypoglycemia||Caution is advised|
Quick GuideType 2 Diabetes Diagnosis, Treatment, Medication
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.